Objective
The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique panel of experts from different disciplines.
ABIRISK will involve many of the European leaders in rheumatology, gastroenterology, hemophilia and multiple sclerosis, caring for ~30,000 patients treated with biopharmaceuticals, with ~10,000 additional patients recruited per year. This should lead to the constitution of the largest possible cohort in Europe for the study of immunogenicity, a condition critical for the success of the program. ABIRISK will also benefit from the unique expertise of immunologist partners in the development of innovative strategies for predicting the immunogenicity of biopharmaceuticals and for defining its mechanisms. The large number of patients enrolled in the ABIRISK cohorts should make it possible to study the genetic basis of immunogenicity in a new way.
We will standardize all clinical and biological information before its integration into a large database for evaluation of the clinical relevance of immunization against biopharmaceuticals and stratification of the risk to patients as a function of factors linked to treatment or to the individual. Computational biology and biostatistical modeling will be used to develop models for predicting immunogenicity that will be validated with the ABIRISK database.
The complementarity between the clinical partners from different disciplines, immunologists, methodologists and biostatisticians will create a unique task force for studies of biopharmaceutical immunogenicity. The direct outcomes of the proposed work will be greater understanding of the mechanisms involved in the emergence of anti-drug antibodies, the development of new methods for predicting immunogenicity and a comprehensive view of the respective value of predictive tools, and guidelines for the development of new biopharmaceuticals and patient care.
Fields of science
- medical and health sciencesclinical medicinerheumatology
- natural sciencescomputer and information sciencesdatabases
- medical and health sciencesbasic medicineimmunologyimmunisation
- medical and health sciencesbasic medicineneurologymultiple sclerosis
- medical and health sciencesclinical medicinegastroenterology
Call for proposal
IMI-JU-03-2010
See other projects for this call
Coordinator
4056 Basel
Switzerland
See on map
Participants (37)
75654 Paris
See on map
50121 Florence
See on map
6500 Bellinzona
See on map
75015 PARIS 15
See on map
DK-2100 Copenhagen
See on map
WC1E 6BT London
See on map
2333 ZA Leiden
See on map
1105AZ Amsterdam
See on map
16147 Genova
See on map
75010 Paris
See on map
31096 Haifa
See on map
53127 Bonn
See on map
63225 Langen
See on map
60323 Frankfurt Am Main
See on map
17177 Stockholm
See on map
6020 Innsbruck
See on map
40225 Dusseldorf
See on map
3400 Hillerod
See on map
4031 Basel
See on map
08035 Barcelona
See on map
E1 4NS London
See on map
81675 Muenchen
See on map
75794 Paris
See on map
53100 Siena
See on map
68167 Mannheim
See on map
116 36 Praha 1
See on map
CT13 9NJ Sandwich
See on map
WC1A 1DG LONDON
See on map
1070 Bruxelles / Brussel
See on map
94250 GENTILLY
See on map
64293 Darmstadt
See on map
2880 Bagsvaerd
See on map
13353 Berlin
See on map
91940 Les Ulis
See on map
52621 Ramat Gan
See on map
54123 SKOVDE
See on map
75012 Paris
See on map